Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | %Female (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
113 | Current Clinical Pharmacology | journal | 0.705 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
112 | Current Drug Abuse Reviews | journal | 1.334 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
111 | Current Psychiatry Reviews | journal | 0.408 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
110 | MicroRNA (Shariqah, United Arab Emirates) | journal | 0.382 Q2 | 29 | 16 | 11 | 0 | 8 | 10 | 0.73 | 0.00 | 42.55 | |
109 | Open Drug Discovery Journal | journal | 0.384 Q3 | 10 | 0 | 26 | 0 | 30 | 23 | 0.00 | 0.00 | 0.00 | |
108 | Pre-Proceedings of the 3rd International Workshop on Collaborative Agents - REsearch and Development, CARE 2011 | conference and proceedings | 0.104 | 1 | 0 | 7 | 0 | 0 | 6 | 0.00 | 0.00 | 0.00 | |
107 | Recent Patents on Computer Science | journal | 0.229 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
106 | Recent Patents on Drug Delivery and Formulation | journal | 0.463 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
105 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.575 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
104 | Recent Patents on Materials Science | journal | 0.198 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
103 | Open Mechanics Journal | journal | 0.245 Q3 | 7 | 1 | 12 | 8 | 9 | 12 | 0.50 | 8.00 | 0.00 | |
102 | Open Transportation Journal | journal | 0.103 Q4 | 13 | 1 | 7 | 20 | 1 | 7 | 0.14 | 20.00 | 0.00 | |
101 | Open Medical Devices Journal | journal | 0.122 Q4 | 5 | 1 | 17 | 41 | 3 | 15 | 0.18 | 41.00 | 0.00 | |
100 | Open Biomarkers Journal | journal | 0.104 Q4 | 7 | 2 | 11 | 64 | 2 | 11 | 0.14 | 32.00 | 80.00 | |
99 | Open Chemical Engineering Journal | journal | 0.211 Q3 | 15 | 4 | 21 | 74 | 15 | 20 | 0.38 | 18.50 | 33.33 | |
98 | Open Transport Phenomena Journal | journal | 0.381 Q2 | 12 | 4 | 20 | 83 | 14 | 20 | 0.88 | 20.75 | 12.50 | |
97 | Open Communication Journal | journal | 0.104 Q4 | 5 | 2 | 5 | 105 | 0 | 5 | 0.00 | 52.50 | 50.00 | |
96 | Open Biotechnology Journal | journal | 0.167 Q4 | 18 | 6 | 14 | 129 | 17 | 14 | 1.38 | 21.50 | 28.57 | |
95 | Open Materials Science Journal (discontinued) | journal | 0.410 Q2 | 17 | 6 | 73 | 134 | 89 | 68 | 0.95 | 22.33 | 28.57 | |
94 | Open Catalysis Journal | journal | 0.200 Q3 | 13 | 5 | 38 | 196 | 34 | 38 | 0.86 | 39.20 | 15.38 | |
93 | Open Ecology Journal | journal | 0.986 Q1 | 18 | 6 | 33 | 210 | 95 | 33 | 0.56 | 35.00 | 20.00 | |
92 | Open Ornithology Journal | journal | 0.246 Q3 | 9 | 4 | 21 | 223 | 11 | 21 | 0.40 | 55.75 | 36.36 | |
91 | Open Anesthesia Journal | journal | 7 | 9 | 21 | 225 | 4 | 15 | 0.25 | 25.00 | 36.73 | ||
90 | Open Petroleum Engineering Journal (discontinued) | journal | 0.139 Q3 | 11 | 12 | 25 | 238 | 7 | 25 | 0.30 | 19.83 | 38.89 | |
89 | Open Medicinal Chemistry Journal | journal | 1.227 Q1 | 23 | 7 | 23 | 247 | 102 | 21 | 4.35 | 35.29 | 43.59 | |
88 | Open AIDS Journal | journal | 0.846 Q2 | 22 | 8 | 70 | 284 | 86 | 69 | 1.33 | 35.50 | 40.63 | |
87 | Open Respiratory Medicine Journal | journal | 0.469 Q2 | 25 | 13 | 51 | 340 | 89 | 47 | 2.00 | 26.15 | 37.50 | |
86 | Open Biomedical Engineering Journal | journal | 0.275 Q3 | 28 | 16 | 55 | 396 | 78 | 53 | 1.21 | 24.75 | 28.77 | |
85 | Open Automation and Control Systems Journal | journal | 0.105 Q4 | 13 | 31 | 4 | 421 | 0 | 4 | 0.00 | 13.58 | 25.88 | |
84 | Current Nanomedicine | journal | 8 | 6 | 0 | 566 | 0 | 0 | 0.00 | 94.33 | 45.83 | ||
83 | Open Civil Engineering Journal | journal | 0.219 Q3 | 21 | 34 | 59 | 583 | 18 | 58 | 0.30 | 17.15 | 26.67 | |
82 | Open Construction and Building Technology Journal | journal | 0.365 Q2 | 27 | 24 | 73 | 643 | 94 | 69 | 1.47 | 26.79 | 18.87 | |
81 | Open Cardiovascular Medicine Journal | journal | 0.490 Q2 | 32 | 22 | 107 | 669 | 205 | 103 | 1.64 | 30.41 | 24.27 | |
80 | Drug Metabolism Letters | journal | 0.340 Q2 | 31 | 26 | 101 | 697 | 128 | 100 | 1.20 | 26.81 | 30.77 | |
79 | Reviews on Recent Clinical Trials | journal | 0.611 Q2 | 35 | 21 | 95 | 788 | 166 | 92 | 1.69 | 37.52 | 20.00 | |
78 | Open Dentistry Journal | journal | 0.293 Q3 | 37 | 29 | 78 | 849 | 77 | 77 | 0.99 | 29.28 | 38.14 | |
77 | Anti-Infective Agents | journal | 0.200 Q3 | 26 | 15 | 45 | 885 | 33 | 43 | 0.70 | 59.00 | 58.62 | |
76 | Current Drug Safety | journal | 0.539 Q2 | 41 | 39 | 170 | 925 | 283 | 157 | 1.28 | 23.72 | 37.40 | |
75 | Nanoscience and Nanotechnology - Asia | journal | 0.155 Q3 | 17 | 15 | 42 | 936 | 16 | 38 | 0.38 | 62.40 | 34.29 | |
74 | Open Hypertension Journal | journal | 0.106 Q4 | 6 | 25 | 5 | 1029 | 1 | 5 | 0.20 | 41.16 | 42.22 | |
73 | Recent Patents on Mechanical Engineering | journal | 0.136 Q4 | 16 | 22 | 64 | 1131 | 11 | 64 | 0.19 | 51.41 | 28.26 | |
72 | Recent Patents on Engineering | journal | 0.220 Q2 | 21 | 19 | 63 | 1156 | 57 | 61 | 0.80 | 60.84 | 21.82 | |
71 | Current Radiopharmaceuticals | journal | 0.555 Q2 | 32 | 26 | 107 | 1359 | 162 | 98 | 1.40 | 52.27 | 39.13 | |
70 | Current Drug Therapy | journal | 0.126 Q4 | 20 | 21 | 106 | 1374 | 30 | 99 | 0.33 | 65.43 | 48.28 | |
69 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.181 Q3 | 17 | 27 | 85 | 1397 | 35 | 79 | 0.46 | 51.74 | 36.44 | |
68 | Current Enzyme Inhibition | journal | 0.231 Q3 | 19 | 18 | 60 | 1416 | 41 | 55 | 0.51 | 78.67 | 39.53 | |
67 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.811 Q2 | 39 | 23 | 97 | 1530 | 226 | 87 | 1.82 | 66.52 | 48.08 | |
66 | Current Angiogenesis | journal | 0.148 Q4 | 6 | 20 | 25 | 1549 | 16 | 24 | 0.64 | 77.45 | 43.68 | |
65 | Recent Patents on Biotechnology | journal | 0.469 Q2 | 42 | 22 | 61 | 1614 | 104 | 58 | 1.55 | 73.36 | 26.47 | |
64 | Clinical Practice and Epidemiology in Mental Health | journal | 0.790 Q2 | 58 | 29 | 71 | 1619 | 165 | 70 | 2.29 | 55.83 | 44.60 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®